Optibrium

Optibrium provides software and artificial intelligence platforms for drug discovery.

Cambridge, UK—Founded 2009—Website

£15.0MTotal raised

Optibrium develops software for drug discovery and small molecule design. Its platform empowers research teams with predictive modelling and artificial intelligence tools.

Founders

Ed Champness

Chief Scientific Officer

Ed is a founder and chief scientific officer at Optibrium, having previously held roles at BioFocus DPI and Inpharmatica.

Investors

Seed21 June 2022
£21
KC
Kester CapitalFollow-on
Growth10 February 2021
£15.0M
KC
Kester CapitalLead

Funding history

Seed21 June 2022

£21

Optibrium secures seed investment from Kester Capital to fund expansion

Kester Capital provides further backing to accelerate the development of computer-aided drug discovery technologies.

Growth10 February 2021

£15.0M

Optibrium secures growth private equity investment from Kester Capital to advance drug discovery software

Kester Capital has backed Cambridge-based Optibrium to drive commercial expansion and product development.